Identification | More | [Name]
Sodium sulfadiazine | [CAS]
547-32-0 | [Synonyms]
4-AMINO-N-[2-PYRIMIDINYL]BENZENESULFONAMIDE SODIUM SALT PERFRINGENS SUPPLEMENT I SODIUM 4-AMINO-N-PYRIMIDIN-2-YL-BENZENESULFONAMIDE SODIUM SULFADIAZINE SPS AGAR SUPPLEMENT SULFADIAZINE SODIUM SULFADIAZINE SODIUM SALT (n(sup1)-2-pyrimidinylsulfanilamido)-sodiu 2-sulfanilamidopyrimidinesodiumsalt 4-amino-n-2-pyrimidinyl-benzenesulfonamidmonosodiumsalt monosodium2-sulfanilamidopyrimidine n(sup1)-2-pyrimidinylsulfanilamidemonosodiumsalt n(sup1)-2-pyrimidinyl-sulfanilamidmonosodiumsalt n(sup1)-2-pyrimidinyl-sulfanilamidn(sup1)-sodiumderiv sodiumsulfapyrimidine solublesulfadiazine sulfadiazine sodium sigmaultra PERFRINGENS SUPPLEMENT I FOR MICRO-BIOL SULFADIAZINESODIUM,USP SULFADIAZINE SODIUM (SD-NA) | [EINECS(EC#)]
208-919-0 | [Molecular Formula]
C10H9N4NaO2S | [MDL Number]
MFCD00067333 | [Molecular Weight]
272.26 | [MOL File]
547-32-0.mol |
Safety Data | Back Directory | [Hazard Codes ]
Xn | [Risk Statements ]
R22:Harmful if swallowed. R36/37/38:Irritating to eyes, respiratory system and skin . R42/43:May cause sensitization by inhalation and skin contact . | [Safety Statements ]
S22:Do not breathe dust . S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S36/37:Wear suitable protective clothing and gloves . S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . | [RIDADR ]
3249 | [WGK Germany ]
3
| [RTECS ]
WP2000000
| [F ]
10-21 | [HazardClass ]
6.1(b) | [PackingGroup ]
III |
Hazard Information | Back Directory | [Chemical Properties]
White to yellow crystalline powder | [Uses]
Sulfadiazine Sodium Salt can be used as reactant/reagent in preparation and crystal structure of aminophenyl sulfonamide tetrahalides, hydrochloride and hydrobromide cocrystals with iodine. | [General Description]
Soluble sulfadiazine is an anhydrous, white, colorless, crystallinepowder soluble in water (1:2) and slightly soluble inalcohol. Its water solutions are alkaline (pH 9–10) and absorbcarbon dioxide from the air, with precipitation of sulfadiazine.It is administered as a 5% solution in sterile waterintravenously for patients requiring an immediately highblood level of the sulfonamide. | [in vivo]
In this study, the effectiveness of Sulfadiazine sodium and Pyrimetamine for the treatment of mice during acute infection with different atypical T. gondii strains was evaluated. Swiss mice were infected with seven T. gondii strainsl. The infected mice were treated with 10-640?mg/kg per day of Sulfadiazine sodium, 3-200?mg/kg per day of Pyrimetamine, or a combination of both drugs with a lower dosage. A descriptive analysis was used to assess the association between susceptibility to sodium and/or Pyrimetamine and the genotype. The TgCTBr4 and TgCTBr17 strains (genotype 108) presented lower susceptibility to sodium or Pyrimetamine treatment. The TgCTBr1 and TgCTBr25 strains (genotype 206) presented similar susceptibility to PYR but not sodium treatment. The TgCTBr9 strain (genotype 11) was the only strain with high susceptibility to treatment with both drugs [1]. | [IC 50]
Toxoplasma |
|
|